Title: Digital Pathology Market by Product, Type, Application & End User - 2022
1MarketsandMarkets Presents
- Digital Pathology Market- Global Forecasts to
2022 -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2- The global digital pathology market is projected
to reach USD 756.1 Million by 2022 from USD 423.1
Million in 2017, at a CAGR of 12.3. The key
factors propelling the growth of this market
include increasing initiatives by governments and
industry players, ease of consultation,
increasing adoption of digital pathology to
enhance lab efficiency, rising prevalence of
cancer, and growing applications of digital
pathology in drug development and companion
diagnostics. - On the basis of product, the market is
categorized into scanners, software,
communication systems, and storage systems. The
software segment is projected to witness the
highest growth rate in the forecast period, due
to the availability of user-friendly, analytical,
and advanced functions for pathology diagnosis.
3-
- http//www.marketsandmarkets.com/Market-Reports/di
gital-pathology-market-844.html - On the basis of type, the digital pathology
market is segmented into human and veterinary
pathology. The human pathology segment is
expected to account for the largest share of the
market in 2017. The increasing number of cancer
research activities and growing collaborations
between academic research institutes,
universities, and pathology laboratories are
driving the increased uptake of digital systems
in human pathology.
4- On the basis of application, the market is
segmented into disease diagnosis,
teleconsultation, drug discovery, and training
education. The teleconsultation segment is
estimated to account for the largest share of the
global digital pathology market in 2017. Shortage
of pathologists in developing countries and
increasing need for quality and fast diagnosis
have enhanced the utilization of teleconsultation
applications across the globe. - On the basis of end user, the global digital
pathology market has been segmented into
pharmaceutical and biotechnology companies,
hospitals and reference laboratories, and
academic research institutes. The
pharmaceutical and biotechnology companies
segment is estimated to account for the largest
share of the global market in 2017. Key factors
driving the growth of this segment is the usage
digital pathology for biobanking,
biopharmaceutical studies, and molecular assays.
5Contact Us
- Mr. RohanMarkets and Markets UNIT no 802, Tower
no. 7, SEZMagarpatta city, HadapsarPune,
Maharashtra 411013, India1-888-600-6441Email
sales_at_marketsandmarkets.com - MarketsandMarkets Blog
- http//www.linkedin.com/company/marketsandmarkets
- http//twitter.com/marketsmarkets
6About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.